These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 2652497
1. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function. Castelao AM, Griñó JM, Sabaté I, Gilvernet S, Andres E, Sabater R, Alsina J. Transplant Proc; 1989 Feb; 21(1 Pt 2):1540-1. PubMed ID: 2652497 [No Abstract] [Full Text] [Related]
2. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation? Posner MP, Mendez-Picon G, King A, Nelson KP, Spicer HG, Lee HM. Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519 [No Abstract] [Full Text] [Related]
3. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function. Woodle ES, Heffron TG, Stuart JK, Thistlethwaite JR, Stuart FP. Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536 [No Abstract] [Full Text] [Related]
4. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients. Cardella CJ, Harding ME, deVeber GA, Honey J, Cook GT. Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065 [No Abstract] [Full Text] [Related]
9. Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation. Kootte AM, van Dorp WT, van Bockel JH, van Es LA, Paul LC. Transplant Proc; 1989 Feb; 21(1 Pt 2):1585-6. PubMed ID: 2652515 [No Abstract] [Full Text] [Related]
10. Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial. Büsing M, Hölzer H, Schareck WD, Mellert J, Greger B, Hopt UT, Lauchart W. Transplant Proc; 1989 Feb; 21(1 Pt 2):1601-3. PubMed ID: 2652521 [No Abstract] [Full Text] [Related]